Name: Return on Equity (ROE)

Definition: ROE shows how much profit the company earns for its shareholders based on their invested equity. It’s one of the most watched profitability ratios. A consistently high ROE signals strong management and efficient use of shareholder capital. But artificially high ROE may sometimes be boosted by excessive debt.

Interpretation:
• In '2020', CHEK's return on equity was -84.5%, measuring profitability for shareholders. Industry average for Medical Electronics in '2020' stood at -84.5%.
• In '2021', CHEK's return on equity was -51.3%, measuring profitability for shareholders. The increase since '2020' reflects strengthening financial performance. Industry average for Medical Electronics in '2021' stood at 0.2%. Industry average increased by 84.7% compared to previous year.
• In '2022', CHEK's return on equity was -41.5%, measuring profitability for shareholders. The increase since '2021' reflects strengthening financial performance. Industry average for Medical Electronics in '2022' stood at -16.3%. Industry average declined by 16.5% from previous year.
• In '2023', CHEK's return on equity was -54.1%, measuring profitability for shareholders. The decline from '2022' may indicate some operational or financial challenges. Industry average for Medical Electronics in '2023' stood at -18.0%. Industry average declined by 1.7% from previous year.
Overall, CHEK's return on equity has been volatile but showed an upward trend over the past 4 years.

Formula: ROE = Net Income / Shareholders' Equity

Good Range: 10%-20% desirable for many industries.